Cetera Investment Advisers Reviva Pharmaceuticals Holdings, Inc. Transaction History
Cetera Investment Advisers
- $80.6 Billion
- Q3 2025
A detailed history of Cetera Investment Advisers transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 60,000 shares of RVPH stock, worth $30,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,000Holding current value
$30,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
50Shares Held
9.74MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...